To Perform Development and Validation of HPLC Method for Analysis of Anticancer Drug Ifosfamide

Authors

  • Rajeshwar V. Chavan  Department of Quality Assurance, Rajarambapu College of Pharmacy, Kasegaon, Maharashtra, India
  • Archna R. Dhole  Department of Quality Assurance, Rajarambapu College of Pharmacy, Kasegaon, Maharashtra, India
  • Vijay R. Salunkhe  Department of Quality Assurance, Rajarambapu College of Pharmacy, Kasegaon, Maharashtra, India

Keywords:

Ifosfamide, HPLC, Method Development, IFF, LOQ, LOD

Abstract

The oretical the as of now distributed Ifosfamide (IFF) explanatory strategies need to muddle techniques and gear, the goal of this paper was to introduce the approval of a straightforward, quick, exact and explicit isocratic UV and HPLC strategy for measurement of Ifosfamide. So this technique will be important during the future improvement of novel or inventive, intravenous medication details for treatment of bosom diseases. Approved technique exhibited Ifosfamide partition without obstracting from the solvents (that is Mensa) with the most significance for creating of intravenous pharmaceutical medication conveys (mensa and ordinary saline water). The UV Spectroscopy, Slope 0.055, Intercept 0.005 and Regression Coefficient 0.997 was found likewise to perform UV Spectroscopy technique approval parameter like linearity (relapse coefficient=0.994), exactness (intraday= % R.S.D.- 0.3203 and interda =% R.S.D-0.3240), precision (97.46-100.23%), LOD (0.3µg/ml) and LOQ (0.91 µg/ml) and toughness (investigator 1= % R.S.D.- 0.80 and examiner 2= % R.S.D- 1.70, power (0.086). Created UV technique is straightforward and monetary. Strategy was direct over considered Ifosfamide focus go (2-10 µg/mL) with passable exactness and precision. LOQ and LOQ 16.05µg/mL and 48.64µg/mL, individually. The Development and approval of Ifosfamide was effectively completed by utilizing UV and HPLC strategy.

References

  1. A. S. Syed and M. Noorullah, analysis of anticancer agents by RP-HPLC – a review article, World Journal of Pharmacy and Pharmaceutical Sciences, 2016; 6(1): page no. 520-530.
  2. T. Ajithkumar, C. Parkinson, F. Shamshad, P. Murray, Ifosfamide encephalopathy Clin Oncol 2007; 19 (2): page no. 108–114.
  3. Beckett AH, Stenlake JB ,Practical Pharmaceutical chemistry , part –II, 4th edition, CBS Publication and Distributor , New Delhi, 1-8; 2002, page no. 157-166.
  4. Snyder LR. Practical HPLC Method development, 2nd edition. John Wiley and Sons, page no. 1-97, 161-168, 653-660.
  5. D. Jain, S. Jain, A. Maulik, “Estimation of metformin hydrochloride, pioglitazone hydrochloride and glimepiride by RP-HPLC in tablet formulation”, Jouranal of Chromatogr Sci, 46(6); 2008, page no. 501-504.
  6. R. Singh, “HPLC method development and validation an overview”, Journal of Pharma Education and Research, 4(1); 2013, page no. 26-31.
  7. R.S. Phani., K.R.S. Prasad and U. M. Reddy, “Scientific approach for RP-HPLC method development complete review”, International Journal of Science Innovations and Discoveries, 2(6); 2012, page no. 218-228

Downloads

Published

2019-10-30

Issue

Section

Research Articles

How to Cite

[1]
Rajeshwar V. Chavan, Archna R. Dhole, Vijay R. Salunkhe, " To Perform Development and Validation of HPLC Method for Analysis of Anticancer Drug Ifosfamide , International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 6, Issue 5, pp.283-299, September-October-2019.